- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02138565
Effect of Bariatric Surgery on Kidney Function (GAS)
Primary hypothesis:
A large reduction in weight is not associated with a change in accurately measured glomerular filtration rate (GFR) (51Chromium ethylenediaminetetraacetic acid plasma clearance (51Cr-EDTA)).
Secondary hypothesis:
A large reduction in weight is associated with a greater change in estimated GFR (The Modification of Diet in Renal Disease (MDRD-formula)) than in accurately measured GFR.
Other formulas for estimated GFR (Cockcroft Gault, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), CKD-EPI with cystatin C) are better correlated with accurately measured GFR.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Gentofte, Denmark, 2820
- Peter Rossing
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male or female, older than 18 years of age
- Appointed to gastric by-pass surgery on Hvidovre Hospital, Denmark
Exclusion Criteria:
- Withdrawal of surgical indication
- Severe oedema or ascites
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bariatric surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in accurately measured GFR
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in estimated GFR (as measured by the MDRD formula, the Cockcroft Gault formula, CKD-EPI formula and CKD-EPI with cystatin C formula).
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
|
Change in 24hour blood pressure
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
|
Change in arterial stiffness (as measured by sphygmocor)
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
|
Change in body composition, as measured by Dual-energy X-ray absorptiometry scan (DXA-scan)
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
|
Change in accurately measured GFR compared with change in estimated GFR
Time Frame: Up to 6 months and 18 months after surgery
|
Up to 6 months and 18 months after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Peter Rossing, Professor, Steno Diabetes Center Copenhagen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 3005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.